Banyu President Quits; Merck VP To Serve As Interim Boss (Japan)
This article was originally published in PharmAsia News
Executive Summary
Banyu Pharmaceutical Co. President Haruhiko Hirate will step down on Sept. 30. David Anstice, executive vice president of the firm's U.S. parent Merck & Co., will take over as interim chief until Hirate's successor is chosen. Hirate took office in January 2004 and, due partly to a lack of new products, failed to increase earnings. Sales totaled less than 200 billion yen in fiscal 2006, well below the target of more than 300 billion yen Hirate had set when he took over as president. (Click here for more - May Require Paid Subscription